Granulocytopenia or agranulocytosis improved with G-CSF or PG-CSF, while thrombocytopenia was alleviated with IL-11, TPO, or oral TPO receptor agonists (TPO-RAs). This evidence concerns the gene TPO and Thrombocytopenia.